RenBio Announces New Awards to Support Continued Development of Its Novel, DNA-Based MYO Technology™ Platform for Antiviral Applications ...Middle East

PR Newswire - News
RenBio Announces New Awards to Support Continued Development of Its Novel, DNA-Based MYO Technology™ Platform for Antiviral Applications
$2.9 Million Received From Wellcome for DNA-Based Delivery of Antiviral Antibodies for Zika and Influenza Prevention, Focusing on Preclinical Development of a Potent Anti-Zika Antibody and Optimizing Antibody Cocktail Delivery $749,000 Contract from the BARDA Flexible and Strategic...

Hence then, the article about renbio announces new awards to support continued development of its novel dna based myo technology platform for antiviral applications was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( RenBio Announces New Awards to Support Continued Development of Its Novel, DNA-Based MYO Technology™ Platform for Antiviral Applications )

Apple Storegoogle play

Last updated :

Also on site :



Latest News